Article
Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration.
Cellular and molecular life sciences : CMLS - 1 Apr 2020
Ibrahim Ridwan Babatunde, Yeh Ssu-Yu, Lin Kon-Ping, Ricardo Frans, Yu Tsyr-Yan, Chan Chih-Chiang, Tsai Jin-Wu, Liu Yo-Tsen
Abstract excerpt
Transthyretin amyloidosis (ATTR) is a progressive life-threatening disease characterized by the deposition of transthyretin (TTR) amyloid fibrils. Several pathogenic variants have been shown to destabilize TTR tetramers, leading to aggregation of misfolded TTR fibrils. However, factors that underlie the differential age of disease onset amongst amyloidogenic TTR variants remain elusive. Here, we examined the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
